Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-29
DOI
10.1111/jcmm.15683
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter
- (2016) Yufei Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer
- (2015) Shusuke Toden et al. CARCINOGENESIS
- The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
- (2015) Daniel Zingg et al. Nature Communications
- DLC1-dependent parathyroid hormone–like hormone inhibition suppresses breast cancer bone metastasis
- (2014) Yufeng Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment
- (2012) Bin Bao et al. PLoS One
- Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression
- (2011) B. Bao et al. CANCER RESEARCH
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
- (2011) Masashi Takawa et al. CANCER SCIENCE
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- Personalized estimates of breast cancer risk in clinical practice and public health
- (2011) Mitchell H. Gail STATISTICS IN MEDICINE
- Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells
- (2010) Wen-Feng Hua et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
- (2010) Junxia Min et al. NATURE MEDICINE
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
- (2010) Ajay Goel et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- DLC1: a significant GAP in the cancer genome
- (2008) A. Lahoz et al. GENES & DEVELOPMENT
- Role of curcumin in health and disease
- (2008) Leelavinothan Pari et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Non-coding RNAs, epigenetics and complexity
- (2007) Fabrício F. Costa GENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started